Semaglutide Lowers Mental Health Risk, Faltings Wins Abel Prize, Pelareorep Delivers in GI Cancers, Lynas Breakthrough Transforms Rare Earth Supply, and more...

brief.news

20 March 2026

(0:10): Study Links Semaglutide to 42% Lower Risk of Worsening Mental Health in Depression, Anxiety Patients(2:26): Gerd Faltings' Pioneering Work in Number Theory Earns Prestigious Abel Prize(4:01): Pelareorep Shows Promise in GI Cancers: GOBLET Trial Exceeds Expectations with 62% Response Rate(6:28): Lynas Achieves Breakthrough in Heavy Rare Earth Processing, Boosts Global Supply Chain Diversification(9:18): Pune's Diabetes Summit Unites Global Experts, Spotlights Innovations & Research AwardsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Público